Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

730
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

1.7K
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
1.7K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

959
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
959
Glucose Transporters01:27

Glucose Transporters

27.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.6K
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

1.4K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
1.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

702
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
702

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Trend in Devices and Digital Tools for Remote Consultation From Medical Providers to Specialists: Scoping Review.

Online journal of public health informatics·2026
Same author

NCPA-templated red-emitting gold nanoclusters: a turn-off-on fluorescent probe for rapid and selective detection of Cu<sup>2+</sup> ions in live cells and evaluation of anticancer activity.

Dalton transactions (Cambridge, England : 2003)·2025
Same author

Effective detection of acetone gas molecules using PLD deposited tungsten oxide microwires for biomedical applications.

RSC advances·2025
Same author

Pathogenic variants prevalence patients with diabetic kidney disease in Japan: A descriptive study.

Journal of diabetes investigation·2025
Same author

A Comprehensive Skin Gas Analysis of Substances Related to Uraemia in Patients With End-Stage Kidney Disease: A Pilot Study.

Nephrology (Carlton, Vic.)·2025
Same author

Noncollinear Magnetism in Fe<sub>3</sub>O<sub>4</sub> Induced via Site-Selective Rare-Earth Substitution Boosting Its Saturation Magnetization.

Small (Weinheim an der Bergstrasse, Germany)·2025

相关实验视频

Updated: Feb 20, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

746

糖尿病病中尿液挥发性有机化合物的SGLT2抑制剂相关变化:一项全面研究

Risa Hara1, Hiroyasu Yamahara2, Yosuke Hirakawa1

  • 1Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Nephrology (Carlton, Vic.)
|February 18, 2026
PubMed
概括

-葡萄糖共运输体-2 (SGLT2) 抑制剂在糖尿病病 (DKD) 患者中增加尿体. 这种非侵入性尿路代谢物概况显示了代谢变化,有助于理解SGLT2抑制剂.

关键词:
这是一种SGLT2抑制剂.这是一个全面的分析分析.糖尿病病 糖尿病病尿液中的挥发性有机化合物

更多相关视频

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.7K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.7K

相关实验视频

Last Updated: Feb 20, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

746
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.7K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.7K

科学领域:

  • 代谢学 代谢学 代谢学
  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 内分泌学 在内分泌学.

背景情况:

  • 起初用于2型糖尿病的-葡萄糖共运输体-2 (SGLT2) 抑制剂,在糖尿病病 (DKD) 中表现出保护作用.
  • 在DKD中SGLT2抑制剂的保护作用背后的代谢机制尚未完全理解.

研究的目的:

  • 通过非侵入性尿路代谢物分析,研究DKD中SGLT2抑制剂的代谢机制.
  • 在DKD患者中识别与SGLT2抑制剂治疗相关的尿液挥发性有机化合物 (VOC).

主要方法:

  • 气色谱-质谱法用于分析61名DKD患者的尿液VOC.
  • 患者被分为接受SGLT2抑制剂治疗和未接受治疗的两组.
  • 鉴定和量化了79种尿液VOC;统计分析了临床变量.

主要成果:

  • 接受SGLT2抑制剂治疗的患者在尿液中呈现出明显更高的乙和2-坦水平.
  • 这些来自体的升高的VOCs表明生成的增加.
  • 研究结果在所有患者中是一致的,并且独立于其他临床特征.

结论:

  • 治疗SGLT2抑制剂与尿相关的VOC增加有关,这表明代谢转向改变了全身能量代谢.
  • 尿液VOC分析为了解SGLT2抑制机制和监测DKD治疗效果提供了一个有希望的非侵入性方法.
  • 这项研究为SGLT2抑制剂提供的脏保护提供了新的机制性见解.